Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC settles false miracle claims

This article was originally published in The Tan Sheet

Executive Summary

FTC banned the marketers of the 7 Day Miracle Cleanse Program, a purported herbal colon-cleansing program, from "involvement in future infomercials for any product, service or program," other than those for informational publications, and from "advertising health-related products ... in any medium," according to the commission. The prohibition is part of a settlement that resolves allegations that Paris DeAguero, Dieter Ammann and Laura DeAguero falsely claimed in an infomercial and online that their herbal supplement regime would cure cancer, AIDS, Alzheimer's and other health problems. They also claimed their product Parasine 2 was "clinically proven" to eliminate parasites and worms. FTC ordered and waived a fine of $14.4 million for the DeAgueros and a $14.4 million fine for Ammann, of which he must pay $70,000, according to the agreement...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101414

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel